Bonus BioGroup Ltd.

BBIXFOTCHealthcare● Active

$0.13

+$0.00(+0.00%)

Market Cap$151830290

P/E Ratio—

52W High$0.15

52W Low$0.0001

Avg Volume238

Open$0.02

Beta0.78

Overview

Bonus BioGroup Ltd. (BBIXF) Revenue

Annual & quarterly revenue history · segment & region breakdown

BBIXF · revenue · updated Jun 9, 2026

Core revenue metrics

Trailing 12 months

Bonus BioGroup Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.

TTM revenue

$0.00B

4-quarter sum · USD

YoY growth

+0.00%

vs FY2025 $0.00B

Price / sales

—

mktCap ÷ TTM rev

Revenue per day

—

Est. TTM ÷ 365

Revenue / employee

$0K

49 employees

FY2025

$0.00B

FY2024

$0.00B

5Y CAGR

—

Fiscal year end

Dec 31

Currency

ILS · GAAP

Filing

10-K / 10-Q

Source: FMP · Bonus BioGroup Ltd. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

2025 – 2012 · Annual

YoY revenue growth %

revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year end	Revenue	Change	Growth
2025-12-31	$0.00B	+$0.00B	—
2024-12-31	$0.00B	+$0.00B	—
2023-12-31	$0.00B	+$0.00B	—
2022-12-31	$0.00B	+$0.00B	—
2021-12-31	$0.00B	+$0.00B	—
2020-12-31	$0.00B	+$0.00B	—
2019-12-31	$0.00B	+$0.00B	—
2018-12-31	$0.00B	+$0.00B	—
2017-12-31	$0.00B	+$0.00B	—
2016-12-31	$0.00B	+$0.00B	—

BBIXF revenue by year · BBIXF revenue history · BBIXF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Bonus BioGroup Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Bonus BioGroup Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in ILS.

Data sourced from Bonus BioGroup Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Price history Financial statements Forecast

Frequently asked questions

BBIXF revenue · 4 questions

BBIXF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.

BBIXF revenueBBIXF annual revenuewhat is BBIXF revenueBBIXF TTM revenue

▸ Source: FMP · Bonus BioGroup Ltd. SEC filings · GAAP · Bonus BioGroup Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026